Kate Dallmier Named NIH T32 Fellow

Chemistry PhD student Kate Dallmier was named a NIH T32 Fellow! Kate is advised by Medicinal Chemistry's Professor Daniel A. Harki and works with him in his laboratory. You can read more about the innovative work of the Harki Lab here.

The NIH T32 training program is meant to enable institutions to recruit individuals for predoctoral and postdoctoral research training in specified shortage areas. The goal is to prepare qualified trainees for careers that have a significant impact on the health-related research needs of the nation.

Kate was selected as a fellow on the Chemistry Biology Interface Training Grant housed here at the University of Minnesota. Predoctoral trainees for this training grant program are selected from a pool of graduate students who have been recruited by the Chemistry; Biochemistry, Molecular Biology & Biophysics (BMBB); and Medicinal Chemistry Departments. You can read more about the CBITG here.

Kate was selected to work with Prof. Daniel Harki and Prof. Hideki Aihara on the synthesis, testing, and structural biology of peptide ligands for APOBEC3B, an enzyme responsible for the deamination of cytidine nucleotides in DNA.

The long-term goal of their project is to develop modulators of APOBEC3 activity due to their role in driving tumorigenesis, metastasis, and treatment resistance in a variety of cancers.

As part of the program, Kate will perform training and research in both the Harki and Aihara labs. She will also attend and present at UMN’s Chemical Biology Colloquia. In addition, she is excited to participate in outreach in the community to promote engagement in STEM by younger students.

This is a great achievement for Kate and something the Medicinal Chemistry Department is very proud of! Fantastic work, Kate!